Clozapine targeting ITIH3 and OXT is a second-generation antipsychotic medication classified as atypical, which is utilized in the management of treatment-resistant schizophrenia and to reduce the risk of suicide in individuals with schizophrenia (Siskind et al., 2016). Here, ITIH3 is linked to schizophrenia.